Patent · US Active

Maintenance of platelet inhibition during antiplatelet therapy

US11510934B2 · kind B2 · utility

0Cited by

18References

10Claims

0Family size

Assignee

Chiesi Farmaceutici S.p.A. · IT

Inventors

Lisa Ruderman Chen · Rye, US
Simona Skerjanec · Basel, CH
Dawn Bell · Morristown, US
Jayne Prats · Carlisle, US
Meredith Todd · Hoboken, US

Key dates

Filing date	Jul 14, 2020
Grant date	Nov 29, 2022
Priority date	—
Expiry date	Aug 25, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients in need of antiplatelet therapy or at risk of thrombosis. The method can further be used in patients who were previously treated with long-acting platelet inhibitors without increasing the risk of excessive bleeding.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.